This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: The University of Nantes, Other. Active years: 2016.
Company Filing History:
1 out of 156 
1 out of 834,350 Years Active: 2016
Title: Verena Stresing: Innovator in Peptide Research
Introduction
Verena Stresing is a prominent inventor based in Nantes, France. She has made significant contributions to the field of biomedical research, particularly in the development of peptides that target the receptor activator of nuclear factor-κB (RANK). Her work is crucial for advancing treatments for diseases related to the RANKL-RANK signaling pathway.
Latest Patents
Verena holds a patent for "Peptides targeting receptor activator of nuclear factor-κB (RANK) and their applications." This invention relates to a polypeptide that can be used as a medicament in the treatment and/or prevention of diseases where the RANKL-RANK signaling pathway is involved, especially in bone resorptive diseases. She has 1 patent to her name.
Career Highlights
Throughout her career, Verena has been associated with the University of Nantes, where she has conducted extensive research. Her innovative work has positioned her as a key figure in her field, contributing to the understanding and treatment of significant health issues.
Collaborations
Verena has collaborated with notable professionals in her field, including Dominique Heymann and Stéphane Teletchea. These collaborations have enhanced her research and expanded the impact of her inventions.
Conclusion
Verena Stresing is a dedicated inventor whose work in peptide research is paving the way for new treatments in medicine. Her contributions are vital for addressing complex health challenges related to bone resorptive diseases.